정부/공공기관
임상시험센터
CRO
분석CRO/센트럴랩
유관기관/협회
정보서비스
해외 유관 기관
* CRO 게재 기준: CRO자율등록 기관
ClinicalTrials.gov에 등록된 정보를 기준으로 코로나-19(COVID-19) 관련 글로벌 임상시험 현황을 제공합니다.
전체 2550건이 검색되었습니다.
No. | Status | Study Title | Conditions | Interventions | Phase | Sponsor/Collaborators | Funder Type | Number Enrolled | Sex | Age | Locations |
---|---|---|---|---|---|---|---|---|---|---|---|
1850 | Terminated | Corticosteroids During Covid-19 Viral Pneumonia Related to SARS-Cov-2 Infection | COVID-19 | Drug: Prednisone Other: Control group |
Phase 2 | Hospices Civils de Lyon | OTHER | 11 | All | 18 Years | Hopital Pneumologique et Cardiovasculaire Louis Pradel, Bron, France Groupement Hospitalier Nord, Lyon, France Hopital Edouard Herriot, Lyon, France Hopital St Joseph Saint Luc, Lyon, France Hopital St Joseph, Marseille, France Centre hospitalier Lyon Sud, Pierre-Benite, France CHU St Etienne, Saint-Etienne, France Clinique Charcot, Sainte-Foy-les-Lyon, France CHG Vienne, Vienne, France Medipole, Villeurbanne, France Clinique des Portes du Sud, Venissieux, France CH Annecy-Genevois, Epagny, France |
1849 | Not yet recruiting | Corticosteroids for COVID-19 | Covid19 | Drug: Prednisone Device: Point of Care testing device for C-reactive protein |
Phase 3 | University of Alberta | OTHER | 1526 | All | 18 Years | Clinica de la Mujer, Bogota, Colombia ABC Medical Center, Mexico City, Mexico |
1848 | Active, not recruiting | CORVax12: SARS-CoV-2 Spike (S) Protein Plasmid DNA Vaccine Trial for COVID-19 (SARS-CoV-2) | SARS-CoV-2 | Drug: CORVax Drug: IL-12 plasmid Device: Cliniporator |
Phase 1 | Providence Health & Services, OncoSec Medical Incorporated | OTHER | 36 | All | 18 Years | Providence Portland Medical Center, Portland, Oregon, United States |
1847 | Recruiting | COVAXIN in a Pediatric Cohort | SARS-CoV2 Infection | Biological: COVAXIN | Phase 3 | Bharat Biotech International Limited | INDUSTRY | 525 | All | 2 Years ~ 18 Years | Victoria Government Hospital, Visakhapatnam, Andhra Pradesh, India All India Institute of Medical Sciences, Patna, Bihar, India Cheluvambha Hospital, Mysore, Karnataka, India Meditrina Institute of Medical Sciences, Nagpur, Maharashtra, India Jawahar Lal Nehru Medical college, Ajmer, Rajasthan, India Pranam Hospitals Hyderabad, Hyderabad, Telangana, India Prakhar Hospital, Kanpur, Uttar Pradesh, India |
1846 | Recruiting | COV-CHIM01: SARS-CoV-2 (COVID-19) Dose Finding Infection Study | Coronavirus | Biological: SARS-CoV-2 virus | Phase 1 | University of Oxford | OTHER | 64 | All | 18 Years ~ 30 Years | Oxford Clinical Research Facility (OxCRF), Oxford, Oxon, United Kingdom Centre for Clinical Vaccinology and Tropical Medicine, Oxford, Oxon, United Kingdom Oxford University Hospital NHS Trust, Oxford, Oxon, United Kingdom |
1845 | Enrolling by invitation | COVFIS-HOME: COVID-19 Pilot Study of Fisetin to Alleviate Dysfunction and Decrease Complications | Coronavirus Infection | Drug: Fisetin | Phase 2 | James L. Kirkland, MD, PhD | OTHER | 150 | All | 18 Years | Mayo Clinic, Rochester, Minnesota, United States |
1844 | Active, not recruiting | CoV-Hep Study: Regional Anticoagulation Modalities in Continuous Venous Venous Hemodialysis in Patients With COVID-19 | Covid19 | Drug: unfractionated Heparin | Not Applicable | University of Sao Paulo General Hospital | OTHER | 118 | All | 18 Years | University of Sao Paulo General Hospital, Sao Paulo, SP, Brazil |